Table 2.
Parameters significantly differing between the groups of NAFLD patients with (n = 17) and without sarcopenia (n = 91).
| Parameter | NAFLD Patients with SARC-F Score ≥ 4 (NAFLD with Sarcopenia, n = 17) | NAFLD Patients with SARC-F Score < 4 (NAFLD without Sarcopenia, n = 91) | p-Value |
|---|---|---|---|
| Gender: female, n (%) | 17 (100) | 51 (56) | 0.001 a |
| Age, years | 56 (51–64) | 48 (40–58) | 0.012 b |
| BMI, kg/m2 | 32.9 (30.6–36.6) | 30.5 (28.5–34.2) | 0.045 b |
| Waist circumference, cm | 102 (100.5–112.3) | 100.5 (94–108.3) | 0.043 b |
| Hip circumference, cm | 116 (113–123) | 110 (105–117.4) | 0.015 b |
| Insulin, μIU/mL | 13.7 (10–20.7) | 10.4 (7.9–14.2) | 0.032 b |
| HOMA-IR | 4.2 (2.9–5.6) | 2.7 (1.9–3.5) | 0.008 b |
| Creatinine, μmol/L | 72 (66.5–77) | 76 (70–87) | 0.032 b |
| FAS ≥ 22, n (%) | 13 (76.5) | 40 (44) | 0.014 a |
| HADS-D ≥ 8, n (%) | 7 (41.2) | 14 (15.4) | 0.014 a |
The presented values denote frequency (%) or median (interquartile range). HADS-A: Hospital Anxiety and Depression Scale, subscale for anxiety; HADS-D: Hospital Anxiety and Depression Scale, subscale for depression; SARC-F: strength, assistance with walking, rise from a chair, stair climbing, and history of falls. a Pearson’s chi-squared test (c2); b Mann–Whitney U test.